Category

Archives

Comparative study between two different morphological structures based on polylactic acid, nanocellulose and magnetite for co-delivery of flurouracil and curcumin

Cellulose was extracted from mango fibers and subjected to acid hydrolysis to obtain a nanofiber. Two morphological structures based on the polylactic acid (PLA)/nanocellulose (NC) combination have been synthesized and Fe3O4 NPs (M) are incorporated into both combinations. The first formulation is obtained by blending technique (PLA/M-NC) and the second formulation is obtained by self-assembly of grafted copolymer (M-PLA-co-NC). The magnetic nanocomposites are used as carriers for 5-fluorouracil (5-FU), an anti-cancer drug, and curcumin (CUR) to get PLA/M-NC/5-FU/CUR and M-PLA-co-NC/5-FU/CUR. The structural, morphological, and magnetic properties of the obtained nanocomposites were characterized by various techniques. The loading, release of 5-FU/CUR and the inhibition efficacy of nanocarriers loaded drugs against bacteria, HePG-2, MCF-7, and HCT-116 cell lines were studied. The two morphological forms of nanocarriers are considered close in loading % of 5-FU; however, the M-PLA-co-NC nanocarrier loaded double the loading % of CUR into PLA/M-NC nanocarrier, revealing superiority of copolymeric micelle than the blended formulation. The dual drugs loaded magnetic copolymeric micelles M-PLA-co-NC/5-FU/CUR revealed slower release, higher antibacterial and antitumor efficacy than the PLA/M-NC/5-FU/CUR. In this respect, the M-PLA-co-NC/5-FU/CUR could be considered a good nanomedicine against Streptococcus, Bacillus subtilis, Klebsiella pneumonia and Escherichia coli bacteria, besides the investigated cell lines.

 

Comments:

Mango fibers were used to extract cellulose, which was hydrolyzed to obtain a nanofiber, then combined with polylactic acid (PLA) and Fe3O4 NPs to create two magnetic nanocomposites (PLA/M-NC and M-PLA-co-NC) that were used as carriers for 5-fluorouracil (5-FU) and curcumin (CUR) to create two dual-drug loaded nanomedicines (PLA/M-NC/5-FU/CUR and M-PLA-co-NC/5-FU/CUR); the latter showed slower release, higher antibacterial and antitumor efficacy, making it a potential nanomedicine against various bacteria and cancer cell lines.

Related Products

Cat.No. Product Name Information
S1209 5-FU (5-Fluorouracil) 5-FU (5-Fluorouracil) is a DNA/RNA synthesis inhibitor, which interrupts nucleotide synthetic by inhibiting thymidylate synthase (TS) in tumor cells. Fluorouracil induces apoptosis and can be used in the treatment of HIV.

Related Targets

DNA/RNA Synthesis Nucleoside Analog/Antimetabolite HIV Thymidylate Synthase Apoptosis related